Iris Jacobs - CSL Behring | 人才画像

基本信息

浏览量：19

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 62 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema

Sarah Walsh, Meaghan Bartlett, Elizabeth M Salvo-Halloran, John Sears, Yinglei Li, Maebh Kelly, Simona Gavata-Steiger, Chiara Nenci,Iris Jacobs,Ingo Pragst, Neelanjana Ray,Imtiaz A Samjoo

Drugs in R&D (2025)

引用0浏览0WOS引用

Population Pharmacokinetic/Pharmacodynamic Analysis of Garadacimab, in Patients with Hereditary Angioedema

Fiona Glassman, Ankur Sharma, Shen Cheng, Curtis Johnston, Bernardo De Miguel Lillo,John-Philip Lawo,Iris Jacobs, Daniel Polhamus, Partha Nandy

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2024）

引用0浏览0引用

Garadacimab for Hereditary Angioedema Attack Prevention: Long-Term Efficacy, Quality of Life, and Safety Data from a Phase 2, Randomised, Open-Label Extension Study

Timothy J. Craig,Donald S. Levy,Avner Reshef,William R. Lumry,Inmaculada Martinez-Saguer,Joshua S. Jacobs,William H. Yang,Bruce Ritchie,Emel Aygoeren-Puersuen,Paul K. Keith,Paula Busse,Henrike Feuersenger, Mihai Alexandru Bica,Iris Jacobs,Ingo Pragst,Markus Magerl

LANCET HAEMATOLOGYno. 6 (2024): e436-e447

引用1浏览0WOS引用

LOW INCIDENCE OF GARADACIMAB IMMUNOGENICITY WITH NO IMPACT ON EFFICACY, SAFETY OR PHARMACOKINETICS: INTEGRATED ANALYSIS

P. Keith, A. Roberts,F. Glassman, H. Shetty,J. Lawo, L. Wieman,I. Jacobs, D. Levy

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGYno. 6 (2024): S32-S32

引用0浏览0引用

GARADACIMAB ELICITS ATTACK-FREE STATUS IN HEREDITARY ANGIOEDEMA INDEPENDENT OF BASELINE CHARACTERISTICS

J. Anderson, J. Bernstein, W. Yang, K. Kohga,K. Sitz,I. Jacobs,H. Feuersenger,R. Tachdjian

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY（2024）

引用0浏览0引用

Population Pharmacokinetic/Pharmacodynamic Analysis Of Garadacimab, In Patients With Hereditary Angioedema

Fiona Glassman, Ankur Sharma, Shen Cheng, Curtis Johnston, Bernardo De Miguel Lillo,John-Philip Lawo,Iris Jacobs, Daniel Polhamus, Partha Nandy

Journal of Allergy and Clinical Immunologyno. 2 (2024): AB4

引用0浏览0引用

A Phase 1, Randomized, Open-label, Parallel-group Study Comparing Pharmacokinetic Properties of Garadacimab Administered by Subcutaneous Pre-filled Syringe Assembled to Autoinjector/Pre-filled Pen Versus Pre-filled Syringe Assembled to Needle Safety Device in Healthy Adults

Fiona Glassman,John-Philip Lawo, Alex Bica,Anthony Roberts, David Kormann, Soeren Miethke, Iwona Dziadowiec,Stephen Caltabiano,Iris Jacobs, Thomas Puchalski

Journal of Allergy and Clinical Immunologyno. 2 (2024): AB7-AB7

引用0浏览0引用

Population exposure-response analysis supports efficacy outcomes of garadacimab in patients with hereditary angioedema

A. Sharma,F. Glassman, R. Garcia, J. French,M. Wiens, B. Miguel-Lillo,J. Lawo,I. Jacobs,D. Polhamus, P. Nandy

CLINICAL PHARMACOLOGY & THERAPEUTICS (2024): S95-S95

引用0浏览0引用

Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis Across 3 Clinical Trials: Phase 2, Pivotal Phase 3, and Open-Label Extension Studies

M. Magerl,T. J. Craig,J. Anderson,J. S. Jacobs,R. Tachdjian,H. Farkas,W. H. Yang,P. Staubach,E. Aygoeren-Puersuen,I. Ohsawa, M. Pollen,J. -P. Lawo, M. A. Bica,I. Jacobs

ALLERGOLOGIEno. 9 (2024)

引用0浏览0引用

Garadacimab for Hereditary Angioedema Prophylaxis: Long Term Efficacy and Safety from the Phase 3 VANGUARD Trial and First Interim Analysis of the Open-Label Extension Trial

A. Reshef,M. Magerl,I. Martinez Saguer,J. A. Bernstein,H. Farkas,W. H. Yang,J. S. Jacobs, P. Hei Li,W. R. Lumry,E. Aygoeren-Puersuen, I. Ohsawa,C. Katelaris,H. Longhurst,R. Hakl,M. Guilarte,E. S. G. Stroes,H. Feuersenger, M. A. Bica,I. Jacobs,T. J. Craig

ALLERGOLOGIE（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn